Profiel
Dakota Gallivan is Chief Healthcare Compliance Officer & VP bij Reata Pharmaceuticals, Inc. De heer Gallivan bekleedde voorheen de functie van Compliance Counsel bij Pharmacyclics LLC. De heer Gallivan is afgestudeerd aan het St. Francis College en heeft een graad in de rechten behaald aan de Seton Hall University School of Law.
Eerdere bekende functies van Dakota Gallivan
| Bedrijven | Functie | Einde |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Compliance Officer | 26-09-2023 |
| DERMIRA, INC. | General Counsel | 01-01-2020 |
| PHARMACYCLICS, INC. | General Counsel | 01-04-2018 |
| Medivation, Inc. /Old/ | General Counsel | 01-04-2017 |
| PFIZER, INC. | General Counsel | 01-04-2017 |
Opleiding van Dakota Gallivan
| St. Francis College | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
